Advanced Renal Cell Carcinoma (RCC) - Pumitamig | Clinical Trial Radar | Bristol-Myers Squibb

Powered by Trial Radar

Advanced

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Bristol-Myers Squibb as a lead sponsor or collaborator. Showing clinical trials for Advanced Renal Cell Carcinoma (RCC). I can help you find nearby clinical trials and understand health conditions and treatments.

Search by location, facility...

Search by keywords...

Study Title	Status
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) NCT07293351	Recruiting